National Eye Institute; Notice of Meeting, 52405-52406 [05-17516]
Download as PDF
<![CDATA[
52405
Federal Register / Vol. 70, No. 170 / Friday, September 2, 2005 / Notices
inhibitors in vitro and can be used to
test drug candidates for their
effectiveness against common drug
resistant mutants of HIV–1 RT. Please
contact Dr. Hughes directly
(hughes@ncifcrf.gov) if you want
additional information about RT
expression plasmids that are not listed
below.
Vector
Description
Reference No.
Wild-type HIV–1 RT .................................................................
L100I ........................................................................................
K103N ......................................................................................
V106A ......................................................................................
V108I ........................................................................................
E138K ......................................................................................
Y181I ........................................................................................
Y181C ......................................................................................
Y188L .......................................................................................
Y188H ......................................................................................
G190A ......................................................................................
G190S ......................................................................................
P236L .......................................................................................
full length, wild type .................................................................
NNRTI resistant .......................................................................
NNRTI resistant .......................................................................
NNRTI resistant .......................................................................
..................................................................................................
NNRTI resistant .......................................................................
..................................................................................................
NNRTI resistant .......................................................................
..................................................................................................
NNRTI resistant .......................................................................
..................................................................................................
..................................................................................................
NNRTI resistant .......................................................................
E–034–1991/0
E–034–1991/1
E–034–1991/1
E–034–1991/1
..............................
E–034–1991/1
..............................
E–034–1991/1
..............................
E–034–1991/1
..............................
..............................
E–034–1991/1
RTs that carry some combinations of NNRTI mutations, e.g., K103N+Y181I, are also available.
K65R ........................................................................................
T69G ........................................................................................
L74V .........................................................................................
M184I .......................................................................................
M184V ......................................................................................
AZT–R (5 mutations) ...............................................................
D67 complex ............................................................................
Q151M .....................................................................................
Q151M Complex ......................................................................
SSGR/T215Y ...........................................................................
SSSR/T215Y ............................................................................
Dated: August 20, 2005.
Steven M. Ferguson,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. 05–17517 Filed 9–1–05; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center on Minority Health and
Health Disparities; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given by the National
Advisory Council on Minority Health
and Health Disparities.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
VerDate Aug<18>2005
18:00 Sep 01, 2005
Jkt 205001
NRTI resistant .........................................................................
..................................................................................................
NRTI resistant .........................................................................
Lamivudine (3TC) resistant .....................................................
Lamivudine (3TC) resistant .....................................................
AZT resistant ...........................................................................
Multi-NRTI resistant .................................................................
Multi-NRTI resistant .................................................................
Multi-NRTI resistant .................................................................
Multi-NRTI resistant .................................................................
Multi-NRTI resistant .................................................................
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Minority Health and Health
Disparities.
Date: September 20, 2005.
Closed: 8:30 a.m. to 10 a.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Suite 800, Bethesda, MD 20892.
Open: 10:30 a.m. to 5:30 p.m.
Agenda: The agenda will include Opening
Remarks, Administrative Matters, Director’s
Report, NCMHD, IC Health Disparities
Research Report, NCMHD Program
Highlights, and other business of the Council.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Suite 800, Bethesda, MD 20892.
Contact Person: Donna Brooks, Asst.
Director for Administration, National Center
on Minority Health and Health Disparities,
National Institutes of Health, 6707
Democracy Blvd., Suite 800, Bethesda, MD
20892, 301–435–2135,
brooksd@ncmhd.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
E–034–1991/2
..............................
E–034–1991/1
..............................
E–034–1991/1
E–034–1991/1
E–034–1991/4
E–034–1991/4
E–034–1991/4
E–034–1991/4
E–034–1991/4
applicable, the business or professional
affiliation of the interested person.
Dated: August 25, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–17514 Filed 9–1–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory Eye Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
E:\FR\FM\02SEN1.SGM
02SEN1
52406
Federal Register / Vol. 70, No. 170 / Friday, September 2, 2005 / Notices
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Eye Council.
Date: September 22–23, 2005.
Open: September 22, 2005, 8:30 a.m. to 3
p.m.
Agenda: Following opening remarks by the
Director, NEI, there will be presentations by
the staff of the Institute and discussions
concerning institute programs.
Place: National Institutes of Health, 5635
Fishers Lane, Terrace Level Conference
Room, Bethesda, MD 20892.
Closed: September 22, 2005, 3 p.m. to 6
p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health, 5635
Fishers Lane, Terrace Level Conference
Room, Bethesda, MD 20892.
Open: September 23, 2005, 8:30 a.m. to
12:30 p.m.
Agenda: Discussions of program policy and
issues.
Place: National Institutes of Health, 5635
Fishers Lane, Terrace Level Conference
Room, Bethesda, MD 20892.
Contact Person: Lore Anne McNicol, PhD,
Director, Division of Extramural Research,
National Eye Institute, National Institutes of
Health, Bethesda, MD 20892, (301) 451–2020.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nei.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: August 25, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–17516 Filed 9–1–05; 8:45 am]
BILLING CODE 4140–01–M
VerDate Aug<18>2005
18:00 Sep 01, 2005
Jkt 205001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Longitudinal
Studies in Sardinia.
Date: September 15, 2005.
Time: 11 a.m. to 12 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes on Aging,
Gateway Building, 7201 Wisconsin Avenue
Room 2C212, Bethesda, MD 20814,
(Telephone Conference Call).
Contact Person: Ramesh Vemuri, PhD,
Health Scientist Administrator, Scientific
Review Office, National Institute on Aging,
National Institutes of Health, Room 2C212,
7201 Wisconsin Avenue, Bethesda, MD
20892–7924, (301) 402–7700, rv23r@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Evolution of
Aging and Dementia in Female Primates.
Date: September 19, 2005.
Time: 9:30 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Gateway Building, 7201 Wisconsin Avenue
Room 2C212, Bethesda, MD 20814,
(Telephone Conference Call).
Contact Person: Jon E. Rolf, PhD, Health
Scientist Administrator, Scientific Review
Office, National Institutes of Health, National
Institute on Aging, 7201 Wisconsin Avenue,
Room 2C212, Bethesda, MD 20814–7924,
(301) 402–7703, rolfj@nia.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Aging Special Emphasis Panel,
Transgenerational Field Trial.
Date: October 4–5, 2005.
Time: 5:30 p.m. to 5 p.m.
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Jon E. Rolf, PhD, Health
Scientist Administrator, Scientific Review
Office, National Institutes of Health, National
Institute on Aging, 7201 Wisconsin Avenue,
Room 2C212, Bethesda, MD 20814, (301)
402–7703, rolfj@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Study of
Elderly Sleep Cycle.
Date: October 5–6, 2005.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Wardman Park Hotel, 2660
Woodley Road NW., Washington, DC 20008.
Contact Person: Bita Nakhai, PhD,
Scientific Review Administrator, Scientific
Review Office, National Institute on Aging,
Gateway Bldg., 2C212, 7201 Wisconsin
Avenue, Bethesda, MD 20814, 301–402–
7701, nakhaib@nia.nih.gov
Name of Committee: National Institute on
Aging Initial Review Group, Behavior and
Social Science of Aging Review Committee.
Date: October 6–7, 2005.
Time: 4 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Jon E. Rolf, PhD, Senior
Health Science Advisor, Scientific Review
Office, National Institute on Aging, National
Institutes of Health, 7201 Wisconsin Avenue,
Room 2C212, Bethesda, MD 20814, 301–402–
7703, rolfj@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Olfactory
Aging.
Date: October 6–7, 2005.
Time: 6 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Chevy Chase, 5520
Wisconsin Avenue, Chevy Chase, MD 20815.
Contact Person: William Cruce, PhD,
Health Scientist Administrator, Scientific
Review Office, National Institute on Aging,
National Institutes of Health, National
Institute on Aging, Room 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20814,
301–402–7704, crucew@nia.nih.gov
Name of Committee: National Institute on
Aging Initial Review Group, Clinical Aging
Review Committee.
Date: October 6–7, 2005.
Time: 6:30 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Alicja L. Markowska, PhD,
DSC, National Institute on Aging, National
Institutes of Health, Gateway Building Room
2C212, 7201 Wisconsin Avenue, Bethesda,
MD 20814, 301–496–9666,
markowsa@nia.nih.gov
Name of Committee: National Institute on
Aging Special Emphasis Panel, Retirement
Cognitions.
E:\FR\FM\02SEN1.SGM
02SEN1
]]>Agencies
[Federal Register Volume 70, Number 170 (Friday, September 2, 2005)]
[Notices]
[Pages 52405-52406]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-17516]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the National Advisory Eye Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C.,
[[Page 52406]]
as amended. The grant applications and/or contract proposals and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications and/or
contract proposals, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Advisory Eye Council.
Date: September 22-23, 2005.
Open: September 22, 2005, 8:30 a.m. to 3 p.m.
Agenda: Following opening remarks by the Director, NEI, there
will be presentations by the staff of the Institute and discussions
concerning institute programs.
Place: National Institutes of Health, 5635 Fishers Lane, Terrace
Level Conference Room, Bethesda, MD 20892.
Closed: September 22, 2005, 3 p.m. to 6 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: National Institutes of Health, 5635 Fishers Lane, Terrace
Level Conference Room, Bethesda, MD 20892.
Open: September 23, 2005, 8:30 a.m. to 12:30 p.m.
Agenda: Discussions of program policy and issues.
Place: National Institutes of Health, 5635 Fishers Lane, Terrace
Level Conference Room, Bethesda, MD 20892.
Contact Person: Lore Anne McNicol, PhD, Director, Division of
Extramural Research, National Eye Institute, National Institutes of
Health, Bethesda, MD 20892, (301) 451-2020.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://www.nei.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.867,
Vision Research, National Institutes of Health, HHS)
Dated: August 25, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-17516 Filed 9-1-05; 8:45 am]
BILLING CODE 4140-01-M
